Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion to treat adult patients with ...
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Green Biologics Ltd. a technology developer and emerging bio-based C4 chemicals producer, focused on renewable n-butanol, based near Oxford, UK announced today the closing of a £15.4 million ($25 million) Series B round led by ...
Tags: Green Biologics, Construction, Decoration
US-based BioMarin Pharmaceutical has announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted in favor of approval of Vimizim for the treatment of Morquio A ...
US-based medical device company Unilife has signed a 15-year global supply contract with Hikma Pharmaceuticals for the use of Unifill prefilled syringes with a range of generic injectable drugs. Unilife will supply customized prefillable ...
Based in Fargo, ND, CSM is a full-service packaging and labeling company that specializes in supplying investigational medicines, including cancer drugs and supplies for clinical trials. CSM's licensed pharmacists and pharmacy technicians ...
Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
Biologics’ Clinical Research Services has announced the addition of frozen storage capabilities to its state-of-the-art facilities and cold-chain packaging and distribution. The new service will allow Biologics to offer a wide range ...
Tags: Biologics, Frozen Storage
GlaxoSmithKline (GSK) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA dry powder ...
Tags: Asthma Treatment, Medicine
Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...
Tags: Cancer Drug, FDA Priority
AstraZeneca has partnered with Taiwan’s National Research Program for Biopharmaceuticals (NRPB) in order to support academic research proposals using 'open innovation' as a catalyst for accelerating drug discovery. The project will ...
The Intellectual Property & Science business of Thomson Reuters has announced the addition of clinical trials intelligence to the Thomson Reuters Cortellis suite, a comprehensive information solution for drug discovery and development. ...
GlaxoSmithKline (GSK) and Danish biotechnology firm Genmab have filed a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) for the use of its leukaemia drug Arzerra (ofatumumab) in combination ...
Tags: GlaxoSmithKline, CLL Patients
Danish pharmaceutical firm Novo Nordisk has received biologics licence application (BLA) approval from the US Food and Drug Administration (FDA) for its recombinant coagulation factor VIII, Novoeight. Novoeight is intended for adults and ...
Tags: Novo Nordisk, Drug